Prevalence of sarcopenia in Asian older adults: A comparison of nine diagnostic criteria across different regions

IF 3.9
Wei-Cheng Chiu , Tung-Wei Kao , Tao-Chun Peng
{"title":"Prevalence of sarcopenia in Asian older adults: A comparison of nine diagnostic criteria across different regions","authors":"Wei-Cheng Chiu ,&nbsp;Tung-Wei Kao ,&nbsp;Tao-Chun Peng","doi":"10.1016/j.exger.2025.112721","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>This study aimed to compare sarcopenia prevalence in older adults using nine diagnostic criteria from different regions to assess how these guidelines influence prevalence rates within the same population. Additionally, we analyzed variations across subgroups to identify factors contributing to prevalence differences.</div></div><div><h3>Methods</h3><div>A total of 1760 participants aged 65–99 were enrolled. Bioelectrical impedance analysis was used to assess muscle mass, while muscle strength and physical performance were evaluated using grip strength, gait speed, and the repeated chair stands test. Sarcopenia prevalence was determined based on definitions provided by ESPEN (European Society for Clinical Nutrition and Metabolism), EWGSOP (European Working Group on Sarcopenia in Older People), IWGS (International Working Group on Sarcopenia), SCWD (Society for Sarcopenia, Cachexia, and Wasting Disorders), AWGS (Asian Working Group for Sarcopenia), FNIH (Foundation for the National Institutes of Health), and SDOC (Sarcopenia Definitions and Outcomes Consortium). Additionally, prevalence rates were assessed across subgroups based on age, sex, and BMI categories.</div></div><div><h3>Results</h3><div>Sarcopenia prevalence varied from 4.8 % (<em>n</em> = 79), based on the FNIH criteria, to 16.1 % (<em>n</em> = 261), according to the EWGSOP criteria. Among females, higher prevalence rates were observed using the ESPEN, AWGS, and EWGSOP2 criteria, while the FNIH criteria indicated a higher prevalence in males. Prevalence increased with age, especially in those aged 85 and older. Lower BMI was associated with higher sarcopenia prevalence according to most criteria, except the FNIH and ESPEN.</div></div><div><h3>Conclusion</h3><div>The notable variability in sarcopenia prevalence across different diagnostic criteria highlights the need for population-specific guidelines. Refining diagnostic criteria to address demographic variations could enhance the accuracy and applicability of sarcopenia assessments. Future studies should aim to further tailor diagnostic approaches and interventions to meet the needs of diverse populations.</div></div>","PeriodicalId":94003,"journal":{"name":"Experimental gerontology","volume":"202 ","pages":"Article 112721"},"PeriodicalIF":3.9000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Experimental gerontology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0531556525000506","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective

This study aimed to compare sarcopenia prevalence in older adults using nine diagnostic criteria from different regions to assess how these guidelines influence prevalence rates within the same population. Additionally, we analyzed variations across subgroups to identify factors contributing to prevalence differences.

Methods

A total of 1760 participants aged 65–99 were enrolled. Bioelectrical impedance analysis was used to assess muscle mass, while muscle strength and physical performance were evaluated using grip strength, gait speed, and the repeated chair stands test. Sarcopenia prevalence was determined based on definitions provided by ESPEN (European Society for Clinical Nutrition and Metabolism), EWGSOP (European Working Group on Sarcopenia in Older People), IWGS (International Working Group on Sarcopenia), SCWD (Society for Sarcopenia, Cachexia, and Wasting Disorders), AWGS (Asian Working Group for Sarcopenia), FNIH (Foundation for the National Institutes of Health), and SDOC (Sarcopenia Definitions and Outcomes Consortium). Additionally, prevalence rates were assessed across subgroups based on age, sex, and BMI categories.

Results

Sarcopenia prevalence varied from 4.8 % (n = 79), based on the FNIH criteria, to 16.1 % (n = 261), according to the EWGSOP criteria. Among females, higher prevalence rates were observed using the ESPEN, AWGS, and EWGSOP2 criteria, while the FNIH criteria indicated a higher prevalence in males. Prevalence increased with age, especially in those aged 85 and older. Lower BMI was associated with higher sarcopenia prevalence according to most criteria, except the FNIH and ESPEN.

Conclusion

The notable variability in sarcopenia prevalence across different diagnostic criteria highlights the need for population-specific guidelines. Refining diagnostic criteria to address demographic variations could enhance the accuracy and applicability of sarcopenia assessments. Future studies should aim to further tailor diagnostic approaches and interventions to meet the needs of diverse populations.
亚洲老年人肌肉减少症的患病率:不同地区九种诊断标准的比较
目的:本研究旨在比较来自不同地区的九种诊断标准在老年人中肌少症的患病率,以评估这些指南如何影响同一人群中的患病率。此外,我们分析了亚组之间的差异,以确定导致患病率差异的因素。方法:共纳入1760名年龄在65-99岁之间的参与者。采用生物电阻抗分析评估肌肉质量,通过握力、步态速度和重复椅架测试评估肌肉力量和物理性能。肌少症的患病率是根据ESPEN(欧洲临床营养与代谢学会)、EWGSOP(欧洲老年人肌少症工作组)、IWGS(国际肌少症工作组)、SCWD(肌少症、恶病质和消瘦症学会)、AWGS(亚洲肌少症工作组)、FNIH(美国国立卫生研究院基金会)和SDOC(肌少症定义和结果联盟)提供的定义确定的。此外,还根据年龄、性别和BMI类别评估了不同亚组的患病率。结果:骨骼肌减少症患病率从4.8 % (n = 79)(基于FNIH标准)到16.1 % (n = 261)(根据EWGSOP标准)不等。在女性中,使用ESPEN, AWGS和EWGSOP2标准观察到较高的患病率,而FNIH标准显示男性患病率较高。患病率随着年龄的增长而增加,尤其是在85岁及以上的人群中。除FNIH和ESPEN外,根据大多数标准,较低的BMI与较高的肌肉减少症患病率相关。结论:不同诊断标准中肌少症患病率的显著差异突出了制定人群特异性指南的必要性。细化诊断标准以解决人口统计学差异可以提高肌少症评估的准确性和适用性。未来的研究应旨在进一步定制诊断方法和干预措施,以满足不同人群的需求。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Experimental gerontology
Experimental gerontology Ageing, Biochemistry, Geriatrics and Gerontology
CiteScore
6.70
自引率
0.00%
发文量
0
审稿时长
66 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信